Vous êtes ici

Abattis Bioceuticals Corp.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
ATT
Indice CSE: 
Devise: 

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds. Abattis develops and is in the process of commercializing natural health products that target ailments and satisfy important market needs. Abattis is conducting ongoing research and development to create plant-based intellectual property and ingredients. Current areas of focus are growth through acquisition and business development and cash flow through commercialization of existing assets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. Abattis follows strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company's website at: www.abattis.com.

Vous êtes ici

Abattis Bioceuticals Corp. (ATT)

SEDAR Information

Abattis Bioceuticals Corp.
Date: juin 22, 2015
Abattis Bioceuticals Corp.
Date: juin 17, 2015
Abattis Bioceuticals Corp.
Date: juin 8, 2015
Abattis Bioceuticals Corp.
Date: mai 27, 2015
Abattis Bioceuticals Corp.
Date: mai 27, 2015
Abattis Bioceuticals Corp.
Date: mai 27, 2015
Abattis Bioceuticals Corp.
Date: mai 27, 2015
Abattis Bioceuticals Corp.
Date: mai 21, 2015
Abattis Bioceuticals Corp.
Date: mai 11, 2015
Abattis Bioceuticals Corp.
Date: mai 6, 2015
Abattis Bioceuticals Corp.
Date: mai 6, 2015
Abattis Bioceuticals Corp.
Date: mai 5, 2015
Abattis Bioceuticals Corp.
Date: mai 1, 2015
Abattis Bioceuticals Corp.
Date: avril 28, 2015
Abattis Bioceuticals Corp.
Date: avril 20, 2015
Abattis Bioceuticals Corp.
Date: avril 15, 2015
Abattis Bioceuticals Corp.
Date: avril 10, 2015
Abattis Bioceuticals Corp.
Date: mars 25, 2015
Abattis Bioceuticals Corp.
Date: mars 24, 2015
Abattis Bioceuticals Corp.
Date: mars 24, 2015
Abattis Bioceuticals Corp.
Date: mars 19, 2015
Abattis Bioceuticals Corp.
Date: mars 16, 2015
Abattis Bioceuticals Corp.
Date: mars 13, 2015
Abattis Bioceuticals Corp.
Date: mars 9, 2015
Abattis Bioceuticals Corp.
Date: mars 2, 2015
Abattis Bioceuticals Corp.
Date: mars 2, 2015
Abattis Bioceuticals Corp.
Date: mars 2, 2015
Abattis Bioceuticals Corp.
Date: mars 2, 2015
Abattis Bioceuticals Corp.
Date: février 17, 2015
Abattis Bioceuticals Corp.
Date: février 17, 2015
Abattis Bioceuticals Corp.
Date: février 10, 2015
Abattis Bioceuticals Corp.
Date: février 10, 2015
Abattis Bioceuticals Corp.
Date: février 10, 2015
Abattis Bioceuticals Corp.
Date: février 10, 2015
Abattis Bioceuticals Corp.
Date: février 6, 2015
Abattis Bioceuticals Corp.
Date: février 6, 2015
Abattis Bioceuticals Corp.
Date: février 6, 2015
Abattis Bioceuticals Corp.
Date: février 4, 2015
Abattis Bioceuticals Corp.
Date: février 4, 2015
Abattis Bioceuticals Corp.
Date: février 4, 2015
Abattis Bioceuticals Corp.
Date: février 4, 2015
Abattis Bioceuticals Corp.
Date: février 3, 2015
Abattis Bioceuticals Corp.
Date: janvier 29, 2015
Abattis Bioceuticals Corp.
Date: janvier 28, 2015
Abattis Bioceuticals Corp.
Date: janvier 28, 2015
Abattis Bioceuticals Corp.
Date: janvier 28, 2015
Abattis Bioceuticals Corp.
Date: janvier 28, 2015
Abattis Bioceuticals Corp.
Date: janvier 28, 2015
Abattis Bioceuticals Corp.
Date: janvier 28, 2015
Abattis Bioceuticals Corp.
Date: janvier 28, 2015
Abattis Bioceuticals Corp.
Date: janvier 27, 2015
Abattis Bioceuticals Corp.
Date: janvier 21, 2015
Abattis Bioceuticals Corp.
Date: janvier 16, 2015

Information d'entreprise

Addresse
224 – 970 Burrard Street
Vancouver, BC V6Z 2R4
Canada
Téléphone
778-883-7869
Courriel
news@abattis.com
URL
http://www.abattis.com
Date d’inscription à la cote
Jeudi, décembre 23, 2010
Agent de transfert
Computershare Investor Services Inc.
Relations avec les investisseurs
Hugh Oswald
Vérificateur
DALE MATHESON CARR-HILTON LABONTE LLP

Advertisement

Publicité

Capitalisation

Capitalisation: 
162698887
Réservé à l'émission: 
0

Bulletins

06/02/2017

2017-0204 - Suspension - Abattis Bioceuticals Corp. (ATT)

Le 6 février 2017

Abattis Bioceuticals Corp. est en défaut de répondre aux exigences du CSE. À compter d'aujourd'hui, le Abattis Bioceuticals sera suspendu conformément à la Politique sur le CST 3. La suspension est considérée comme un Arrêt de la réglementation tel que défini dans le Règlement 23-101 sur les Règles de Négociation. La Commission des valeurs mobilières de l'Ontario et de l'Colombie britannique a émis un ordre de cessation d'activité.

Date: À compter du Le 6 février 2017